TY - JOUR
T1 - Schedule shifts, cancer and longevity
T2 - Good, bad or indifferent?
AU - Cornelissen-Guillaume, Germaine G
AU - Halberg, Julia
AU - Halberg, Franz
AU - De La Pena, Salvador Sanchez
AU - Nelson, Walter
AU - Schwartzkopff, Othild
AU - Stoynev, Alexander
AU - Haus, Erhard
PY - 2008
Y1 - 2008
N2 - Prompted by a recent report of the possible carcinogenic effect of shiftwork focusing on the disruption of circadian rhythms, we review studies involving shifts in schedule implemented at varying intervals in unicells, insects and mammals, including humans. Results indicate the desirability to account for a broader-than-circadian view. They also suggest the possibility of optimizing schedule shifts by selecting intervals between consecutive shifts associated with potential side-effects such as an increase in cancer risk. Toward this goal, marker rhythmometry is most desirable. The monitoring of blood pressure and heart rate present the added benefit of assessing cardiovascular disease risks resulting not only from an elevated blood pressure but also from abnormal variability in blood pressure and/or heart rate of normotensive as well as hypertensive subjects.
AB - Prompted by a recent report of the possible carcinogenic effect of shiftwork focusing on the disruption of circadian rhythms, we review studies involving shifts in schedule implemented at varying intervals in unicells, insects and mammals, including humans. Results indicate the desirability to account for a broader-than-circadian view. They also suggest the possibility of optimizing schedule shifts by selecting intervals between consecutive shifts associated with potential side-effects such as an increase in cancer risk. Toward this goal, marker rhythmometry is most desirable. The monitoring of blood pressure and heart rate present the added benefit of assessing cardiovascular disease risks resulting not only from an elevated blood pressure but also from abnormal variability in blood pressure and/or heart rate of normotensive as well as hypertensive subjects.
UR - http://www.scopus.com/inward/record.url?scp=58649089762&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=58649089762&partnerID=8YFLogxK
M3 - Review article
C2 - 19227006
AN - SCOPUS:58649089762
SN - 1359-4117
VL - 7
SP - 263
EP - 273
JO - Journal of experimental therapeutics & oncology
JF - Journal of experimental therapeutics & oncology
IS - 4
ER -